Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma

Clinical trial NCT00410605 · COMPLETED

Trial details

NCT number: NCT00410605
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Stage II Multiple Myeloma Stage III Multiple Myeloma

Start date: 2006-11-01
Primary completion: 2011-12-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.